Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet, 393(10170), 434-445. and the Otago Southland Diabetes Research Trust. 94 the light of current evidence, dietary glycaemic index or glycaemic load may be less useful as overall measures 95 of carbohydrate quality than dietary fibre and wholegrain content.
Background Previous systematic reviews and meta analyses explaining the relationship between carbohydrate 26 quality and health have usually examined a single marker and a limited number of clinical outcomes. We have 27 considered the impact of carbohydrate quality as measured by intakes of dietary fibre, whole grains or pulses, 28 and dietary glycaemic index or glycaemic load on non-communicable disease (NCD) incidence, mortality, and 29 risk factors to more precisely quantify the predictive potential of the markers, to determine which are most 30 useful, and to establish an evidence base for quantitative recommendations for intakes of dietary fibre.
32
Methods Prospective studies published prior to April 2017 and randomised controlled trials published prior to 33 February 2018, which reported on indicators of carbohydrate quality and NCD incidence, mortality and risk 34 factors were systematically reviewed and meta analysed. Studies were identified by searches in PubMed, Ovid 35 Medline, Embase, and the Cochrane Central Register of Controlled Trials and by hand searching of previous 36 publications. Searches, data extraction, and bias assessment were duplicated independently. Robustness of 37 pooled estimates from random effects models was considered with sensitivity analyses, meta regression, dose 38 response testing, and subgroup analyses. The GRADE approach was used to assess quality of evidence.
40
Findings 135 million person years of data from prospective studies and 58 clinical trials with a total of 4,635 41 adult participants were included in the analyses. Observational data suggest a 15-30% decrease in all-cause and 42 cardiovascular related mortality, and incidence of coronary heart disease, stroke, type 2 diabetes, and colorectal 43 cancer when comparing the highest dietary fibre consumers with the lowest. Clinical trials show significantly 44 lower body weight, systolic blood pressure and total cholesterol when comparing higher with lower intakes.
45
Risk reduction associated with a range of critical outcomes was greatest when daily intake of dietary fibre was 46 between 25-29 grams. Dose response curves suggested that higher intakes may confer even greater benefit with 47 regard to protection against cardiovascular diseases, type 2 diabetes and colorectal and breast cancer.
48
Comparable findings for wholegrain intake were observed. Smaller or no risk reductions were found with the 49 observational data when comparing the effects of diets characterised by low rather than higher glycaemic index 50 or load. Overall the certainty of evidence regarding the relationships between carbohydrate quality and critical 51 outcomes was graded as moderate for dietary fibre, low to moderate for whole grains, and low to very-low for 52 glycaemic index. Data relating to other dietary exposures was limited.
54
Interpretation The complementary findings from prospective studies and clinical trials relating to the reduction 55 in mortality, NCD incidence, and their risk factors associated with relatively high intakes of dietary fibre and 56 whole grains as well as striking dose response evidence indicate that the relationships may be causal. Benefit to 57 individuals and populations may be expected from implementation of dietary recommendations to increase 58 dietary fibre intake and to replace refined grains with whole grains.
Evidence before this study 65 Carbohydrate-containing foods consisting principally of sugars, starches and dietary fibre (non starch 66 polysaccharide) provide the major source of energy worldwide. The role of free sugars as a determinant of 67 adverse health outcomes has been clarified and clear guidelines relating to their restriction issued. Dietary fibre 68 and some starches are associated with health benefits and dietary guidelines typically encourage regular 69 consumption of vegetables, cereals, pulses and whole fruit which are rich sources of these and other health 70 promoting nutrients. However, previous systematic reviews and meta analyses examining the relationship 71 between starches and dietary fibre, and health outcomes have usually examined a single indicator of 72 carbohydrate quality and a limited number of disease outcomes. Thus it has not been possible to determine the 73 extent to which the predictive potential of these indicators applies across the spectrum of non-communicable 74 disease (NCDs) nor which are most useful in nutrition guidelines or when recommending food choices.
75
Quantitative recommendations relating to dietary fibre have not had a strong evidence base.
77
Added value of this study
78
We have undertaken systematic reviews and meta analyses of prospective studies and clinical trials that have 79 reported on the relationship between the most widely studied indicators of carbohydrate quality (dietary fibre, 80 whole grains or pulses, dietary glycaemic index or glycaemic load) and mortality and incidence of a wide range 81 of NCDs and their risk factors. Parallel consideration of prospective studies and clinical trials has enabled an 82 exploration of the extent to which changes in cardiometabolic risk factors associated with altering intake of 83 dietary carbohydrate align with the effect of carbohydrate quality on disease risk observed in the prospective 84 studies. Dose response curves were generated and the benefits from different amounts of total dietary fibre were 85 calculated. The approach recommended by the GRADE Working Group has been used to assess the quality of 86 evidence and the magnitude and importance of the observed associations which influence the confidence in 87 nutrition recommendations.
89
Implications of all the available evidence 90 The complementary findings from prospective studies and clinical trials, which show that higher intakes of 91 dietary fibre or whole grains are related to a reduction in the risk of a wide range of NCDs and their risk factors, 92 provide convincing evidence for nutrition recommendations to replace refined grains with whole grains and 93 increase dietary fibre to at least 25-29g per day, with additional benefits likely to accrue with greater intakes. In
Introduction 97
Prior to the mid twentieth century carbohydrates were principally regarded as an energy source and nutrition 98 recommendations suggested that carbohydrates should contribute the energy deficit remaining after intakes of 99 fat and protein had been specified. From the mid 1950s there was increasing awareness of the potential of 100 "sugar" (principally sucrose) to increase the risk of dental caries and in the 1960s Yudkin 1 popularised the view 101 that sugar was a major contributing cause of obesity, type 2 diabetes and cardiovascular disease, an opinion 102 shared by Cleave and Campbell who described these and other chronic conditions as saccharine diseases. 2 A 103 substantial body of experimental, epidemiological and clinical trial data has accumulated since these early 104 observations and based on extensive systematic reviews and meta analyses, the World Health Organization 105 (WHO) has recently issued a strong recommendation, based on the association between free sugars and dental 106 caries and obesity, for individuals to reduce intake to less than 10% total energy and a conditional 107 recommendation suggesting that even greater benefit may accrue if intakes are below 5%. 3 Comparable 108 recommendations have been made by national governments and professional organisations worldwide.
110
It is more than half a century since Burkitt, Trowell and Painter, based largely on epidemiological observations 111 in Africa, suggested that processing of cereal based foods (grains) with removal of what came to be called 112 dietary fibre, rather than excessive intakes of sugar, were key determinants of both cardiometabolic and large 113 bowel diseases. 4,5 Nevertheless, until relatively recently rather less attention has been given to starches and 114 dietary fibre, the other major components of dietary carbohydrate. While nutrition guidelines issued by many 115 governments and professional organisations encourage increased consumption of vegetables, fruit and whole 116 grains, there are fewer quantitative guidelines for sources and intakes of dietary fibre and starch. We report here 117 on a series of systematic reviews and meta analyses on indicators of carbohydrate quality and non-118 communicable disease (NCD) incidence, mortality, and risk factors. The research was commissioned by WHO 119 to inform the development of updated recommendations regarding carbohydrate intake. 120 121
Methods 122
We followed reporting standards for systematic reviews and meta analyses. 6 Literature searches, identification 123 of eligible studies, data extraction and bias assessment were undertaken independently by at least two 124 researchers, with discrepancies resolved with an additional reviewer.
126
PICO tables and eligibility criteria 127 PICO tables (Appendix A) were agreed by the WHO Nutrition Guidance Expert Advisory Group (NUGAG).
128
We report here on markers of carbohydrate quality that have been measured in an appreciable number of studies 129 and trials (dietary fibre, dietary glycaemic index or glycaemic load, and wholegrain intake) and outcomes 130 specified in the PICO tables. For prospective studies critical outcomes included all-cause, coronary heart disease 131 (CHD) and stroke mortality and incidence of CHD, stroke, type 2 diabetes, and colorectal cancer. Important 132 outcomes included cardiovascular disease (CVD) incidence and mortality and incidence of adiposity-related 133 cancers (breast, endometrial, oesophageal, and prostate). Prospective studies which included only cohorts with 134 specified pre-existing conditions were excluded. 135 136 triglycerides, cholesterol, and blood pressure. We included parallel and crossover randomised clinical trials of at 138 least four weeks duration that reported on higher compared with lower intakes of the dietary markers. Eligible 139 trials could include diets with test foods provided, dietary advice, ad libitum diets or controlled feeding trials on 140 free living individuals. Weight loss trials and trials involving provision of dietary fibre supplements in the forms 141 of powders were excluded. Comparison diets were required to be matched for macronutrient composition and 142 lifestyle modifications such as exercise.
144
Participants of eligible trials were adults and children free from acute or chronic disease but could include those 145 with prediabetes, mild-moderate hypercholesterolemia, mild-moderate hypertension or metabolic syndrome.
146
Trials including people on medications known to effect outcomes of interest or who were pregnant or in 147 situations where regular eating habits were likely to change e.g. those suffering from eating disorders or who 148 were breast feeding were excluded.
150

Literature search
151
Prospective observational studies were initially identified from systematic reviews and meta analyses that 152 reported associations between carbohydrate intake or one of the specified measures of carbohydrate quality, and 153 one or more of the key outcome measures. These systematic reviews were found through online searches using 
168
Where there were multiple publications from the same cohort, we used data for the longest follow-up period.
170
Data extraction 171 Data were extracted using pre-tested forms. 7 For prospective studies the most adjusted values for effect size 172 were extracted, where that value did not also specifically include adjustment for other carbohydrates. For 
176
Risk of bias assessment
178
We used the ROBIS assessment tool 8 to assess systematic reviews and meta analyses for quality and risk of 179 bias, and the Newcastle Ottawa Scale (NOS) 9 to assess risk of bias of each prospective study. For clinical trials 180 we used Cochrane criteria. 10 181 182
Data analysis
183
For prospective studies we pooled the reported odds ratios or risk ratios with the DerSimonian and Laird 184 random effects model 11 in a high quantile versus low quantile analysis. When individual studies reported results 185 separately by sex, we first combined these effect size estimates with a fixed effects model before including them 186 within the pooled estimate. When eligible studies were based on and reported combined results from multiple 187 cohort studies we extracted results for each cohort to include in the meta-analysis. Prospective studies reporting 188 incidence or mortality were analysed separately. Where data were reported in a suitable format, we considered 189 dose response relationships with the Greenland and Longnecker method 12 assuming linearity with a two-stage 190 dose response random-effects analysis. The average or mid-point of each defined quantile was used for the dose 191 amount. Where the quantile dose range was open-ended, half the range of the adjacent quantile was used to 192 determine the average intake. We used 30g to represent one serve of whole grains when a value for weight was 193 not stated. 13 Non-linear dose-response was assessed using restricted cubic splines with three knots at 10%, 50%, 194 and 90% of distribution combined with multivariate meta analyses. 14 To help establish optimal intakes of dietary fibre we considered the dose-response curves for total dietary fibre 200 intake and critical health outcomes. We also compared the lowest consumers of dietary fibre with those 201 consuming between 15-19, 20-24, 25-29, 30-34, and 35-39 grams of fibre per day with a random effects model.
202
When studies reported more than one quantile of data within the pre-specified intake ranges, we first combined 203 these quantiles with a fixed effects model before including them within the pooled estimate. We did this to 204 measure the number of critical outcomes where an improvement in relative risk was observed in the higher 205 intake categories.
207
For clinical trials high-versus-low analyses were undertaken with generic inverse models and random-effects.
208
For outcomes that could be measured by different units, reported effects were presented as standardised mean 209 differences. For studies reporting multiple follow-ups over time, the most recent, appropriately reported 210 published data were used in the meta analyses. When crossover (paired data) studies did not report the mean 211 difference between treatments and its standard error or other relevant statistics, end of treatment values were 212 analysed as independent samples. Subgroup analyses by fibre amount or principal starch source were conducted 213 when there were enough studies for subgroupings including more than one trial. For example high fibre 214 interventions (0-25, 25-30, 30-35, >35 g/day) were considered to determine whether there were threshold effects 215 or a possible dose response.
216
For all analyses heterogeneity was assessed with the I 2 statistic, 16 and the Cochrane Q test. 17 Sensitivity analyses 218 were conducted when a I 2 statistic was found to be more than 50% or a p for heterogeneity of <0·10. Publication 219 bias was assessed with Egger's and Begg's tests, 18 and the trim and fill method. 19 The effect of each individual 220 study's findings was considered with an influence analysis. For prospective studies analyses excluding those 221 that scored less than six out of a possible nine with the NOS were conducted. If there was still unexplained 222 heterogeneity we considered the impact of small studies reporting less than 200 cases or less than 2000 223 participants. For clinical trials, analyses excluding trials with a high risk of bias for at least one criterion were 224 conducted to examine the influence of potential bias on outcomes. Meta regression analyses further examined 225 effects of potential explanatory factors including trial design (crossover or parallel), study or trial duration, 226 global region, differences in fibre intake achieved, source of fibre or starch and nutrition status of participants.
227
Analyses were performed using the Cochrane Collaboration software and Stata statistical software. 20, 21 228 229
We used GRADE 22 protocols, to judge the quality of the body of evidence as either high, moderate, low, or The observational data in Table 1 show that higher intakes of total dietary fibre are associated with a 15-31% 249 reduction in the risk of specified critical outcomes. For all-cause mortality and coronary heart disease incidence 250 this translates into 13 fewer deaths (95%CI 8 to 18) and 6 fewer cases of CHD (95%CI 4 to 7) per 1000 251 participants over the duration of the studies. Sensitivity analyses of the tested associations did not change the 252 direction or significance of any observed result. The quality of evidence contributing to the meta analyses of the 253 cohort studies was, with the exception of the data relating to stroke, considered to be moderate.
255
Figure 2 shows dose response relationships for total fibre intake and total mortality, incidence of coronary heart 256 disease, type 2 diabetes and colorectal cancer, many of which are linear with no sign of a plateau within the 257 available data. When comparing the lowest fibre intakes with pre-specified ranges the greatest benefits were 258 observed for those consuming 25-29g per day (improvement in 6 of the 7 critical outcomes), more so than those 259 consuming between 15-19g per day (improvement in 3 of the 7 critical outcomes), or 20-24g per day 260 (improvement in 4 of the 7 critical outcomes). These analyses are shown in full in Appendix B.
262
Mean differences between higher versus lower fibre intakes for a range of cardiometabolic risk factors are 263 shown in Table 1 and the summary forest plots in Figure 5a . Dose response or threshold effects could not be 264 determined from the clinical trial data. The quality of evidence contributing to the meta analyses of the trial data 265 relating to body weight is high and total cholesterol and systolic blood pressure moderate because of 266 unexplained heterogeneity between the trials.
268
Broadly similar effects were apparent in both the prospective studies and clinical trials, when examining fibre 269 from different food groups or fibre described as soluble or insoluble, though limited data were available, other 270 than for cereal fibre, the largest contributor to total dietary fibre (Supplements 1-9).
272
Whole grains 273 Cohort data showing the relationship between whole grains and the effect of increasing wholegrain intake on 274 critical outcomes are shown in Table 2 . Higher intakes of whole grains were associated with a 13-33% reduction 275 in the risk. For all-cause mortality and coronary heart disease incidence this translates into 26 fewer deaths 276 (95%CI 14 to 39) and 7 fewer cases (95%CI 3 to 10) per 1000 participants over the duration of the studies.
277
Sensitivity analyses did not typically change the direction or significance of any pooled effect. The quality of 278 evidence relating to colorectal cancer incidence is moderate, whilst for other critical outcomes it is low due to 279 high heterogeneity not fully explained by sensitivity analysis. Dose response curves showing clear associations 280 with increasing wholegrain intake and all-cause mortality or risk of coronary heart disease, type 2 diabetes, and 281 colorectal cancer incidence are shown in Figure 3 . Mean differences in cardiometabolic risk factors between 282 higher and lower wholegrain consumption are shown in Table 2 
292
An 11% (95%CI 3% to 18%) relative risk reduction of type 2 diabetes was observed for those consuming low 293 glycaemic index diets. However sensitivity analysis due to high heterogeneity attenuated the relative risk 294 reduction to 5% (95%CI 13% less to 4% more). Stroke mortality was lower amongst those consuming lower result of high risk of bias, imprecision, and inconsistencies. Key outcome markers from the clinical trials on 297 decreasing the glycaemic index of a diet are shown in forest plots in Figure 5c . Trial data were usually of 298 moderate quality.
300
Discussion 301
Higher intakes of total dietary fibre or whole grains result in reduced incidence and mortality from several 302 NCDs. Less useful markers of carbohydrate quality are glycaemic index, glycaemic load, and sources of dietary 303 fibre where inconsistent findings or insufficient data provide low or very low quality evidence. In randomised 304 trials higher intakes of dietary fibre reduce body weight, lower blood cholesterol and systolic blood pressure.
305
These findings are supported by cohort studies that report reduced risk of coronary heart disease incidence and 306 mortality and diabetes incidence. The consistency between the trial and prospective study results together with 307 the dose response relationships are evidence that the effect on cardiometabolic diseases are likely to be causal 308 and not a consequence of confounding. In addition, prospective studies show striking reductions in and dose 309 response relationships with all-cause mortality, total cancer deaths, total cardiovascular disease, stroke 310 incidence, and colorectal, breast, and oesophageal cancer. For several of these outcomes the dose response is 311 linear. These findings together with the comparisons of clinical outcomes amongst those with different intakes 312 of dietary fibre suggest that individual adult intakes of total dietary fibre should be no less than 25 to 29 grams 313 per day with additional benefits likely to accrue with higher intakes. Population intakes in this range are 314 reported in some countries, but the majority consume less than 20 grams a day. 23 Broadly similar trends were 315 apparent in the prospective studies that examined cereal fibre, typically the largest contributor to total dietary 316 fibre. Limited data were available regarding specific sources (legume, fruit, vegetable) or subcategories 317 ('soluble', 'insoluble', or extracted) of dietary fibre.
319
The results for wholegrain foods reflect those for dietary fibre. Prospective studies showed a reduction in all-320 cause mortality, coronary heart disease, cancer deaths, and incidence of type 2 diabetes. As with dietary fibre 321 the observed reductions in risk are considerable, typically around 20% with significant dose response 322 relationships. The randomised controlled trials involving an increase in the amount of whole grains showed 323 improvements in body weight and lipids. The similar protective effects of higher intakes of wholegrain foods 324 and of dietary fibre suggest that the beneficial effects of whole grains may be due to their typically high dietary 325 fibre content. The GRADE criteria categorise the evidence linking most clinical outcomes with dietary fibre as 326 moderate, and with whole grains as low quality.
328
Dietary starch can be divided into several categories 24 although rarely are measurements made of these 329 individual components in either prospective studies or randomised controlled trials. However the glycaemic 330 index of starch-containing foods or the overall glycaemic load of meals or diets including starchy foods provide 331 measures of starch quality and are widely reported. We have found that diets with a lower overall glycaemic 332 index appear to be associated with a reduced risk of stroke and type 2 diabetes. However the risk estimates, 333 other than for stroke mortality, are modest when compared with those for dietary fibre and following sensitivity 334 analyses were reduced and associated with confidence intervals which included 1. The findings from 335 prospective studies of glycaemic load are inconsistent. The results from trials show no consistent benefits on the 336 clinical outcomes when changing the glycaemic index of a diet.
338
A major strength of the present study is that it has related key markers of carbohydrate quality to total mortality 339 and mortality and incidence of the major nutrition-related non-communicable diseases and that prospective 340 studies have been considered alongside randomised controlled trials. Other reviews and meta analyses have 341 reported on a single indicator of carbohydrate quality and one or more outcomes. Our approach has enabled us 342 to use these indicators of carbohydrate quality to provide a stronger justification than had previously been 343 available for a quantitative recommendation relating to dietary fibre intake. That the evidence for the 344 associations between the quality markers and outcomes was most frequently rated as 'moderate' or 'low' rather 345 than 'high' may be regarded as a limitation. However this is an inevitable consequence of the use of GRADE 346 criteria for assessment which typically require evidence from randomised controlled trials with disease 347 endpoints in order to be rated as being of 'high'. Furthermore when using the GRADE approach downgrading 348 frequently occurs as a consequence of unexplained heterogeneity amongst the results of the different studies, 349 even when all trend in a similar direction. This may be a consequence of studies being carried out in diverse 350 populations or as a result of different methods of measuring dietary intake. With regard to the associations we 351 have reported here between dietary fibre and whole grains and a wide range of clinical outcomes, the 352 consistency of the findings, the striking dose response relationships and the substantial body of mechanistic 353 evidence all contribute to the totality of evidence and increases our confidence in the findings.
355
Our findings are broadly comparable with other reviews and meta analyses that have reported on the association 356 between dietary fibre and whole grains and one or more disease outcomes. [25] [26] [27] [28] However there is less consistency 357 in our findings than in earlier reports with regard to the potential benefit of low glycaemic index or glycaemic 358 load diets. Three systematic reviews have shown a reduced incidence of type 2 diabetes associated with the 359 consumption of diets of lower glycaemic index or glycaemic load, 29-31 though the effect was modest when 360 compared with the protective effect of total dietary fibre or wholegrains. In the present study sensitivity analyses 361 due to high heterogeneity reduced risk reduction and confidence intervals included 1. A review of prospective 362 studies by Turati et al. 32 suggested a small but significant increase in colorectal cancer incidence associated with 363 high glycaemic index or glycaemic load. This finding was subject to high unexplained heterogeneity and 364 included retrospective case-control studies which may be subject to dietary recall bias. Other studies have 365 reported a lower incidence of stroke and CHD amongst those consuming low glycaemic index or glycaemic load 366 diets, 29,33-36 whilst we found a reduced risk of stroke only. We were unable to confirm an effect of low 367 glycaemic index or glycaemic load diets on haemoglobin A1 c or blood cholesterol which have been reported in 368 many short and medium term trials. However we excluded trials which involved only people with diabetes or 369 marked hyperlipidaemia who were the participants in the majority of trials reporting reduction in these 370 important risk indicators. Our study does not exclude the value of these indicators of carbohydrate quality in this 371 clinical context.
373
Whole grains offer a useful means of increasing dietary fibre intake and reducing risk of NCDs. However fruit 374 and vegetables are also important contributors to dietary fibre intake. We did not specifically explore the 375 relationship between fruit and vegetable consumption and NCDs given the recent systematic review and meta 376 analyses by Aune et al. 37 They report risk reductions of around 10% per 200g fruit and vegetables combined for 377 CHD, stroke and total mortality and smaller but still significant reductions for total cardiovascular disease and 378 cancer. Appreciable dose response effects were apparent for most outcomes up to 800g/day. Inverse associations 379 were observed between the intake of apples, pears, citrus fruits, green leafy vegetables, cruciferous vegetables 380 and salad and cardiovascular disease and all-cause mortality. Intake of green yellow vegetables and cruciferous 381 vegetables were inversely associated with total cancer risk In addition to fibre, fruits and vegetables contain 382 many other nutrients that are potentially protective and confer some risk reduction.
384
The benefits of fibre reported in the present and other papers are supported by over 100 years of research into its 385 chemistry, physical properties, physiology and metabolic effects. 23, [38] [39] [40] Fibre containing foods must be chewed 386 before passing through the stomach and into small bowel where they affect satiety, glucose and insulin 387 responses and lipid absorption. Whilst more recent systematic reviews have shown only small effects on 388 appetite, satiety or blood lipids 41,42 these studies have been conducted largely using defined fibre supplements 389 rather than whole foods. Whole foods that require chewing and retain much of their structure in the gut are more 390 likely to increase satiety through a variety of mechanisms leading to weight loss and to modulation of 391 carbohydrate and lipid metabolism. In the large bowel fibre is almost completely broken down by the resident 392 microflora in a series of anaerobic reactions known as fermentation. 43 The gut microbiota play a number of 393 important roles in human health including protecting against pathogens, development of the gut immune system, 394 vitamin synthesis, metabolism of xenobiotics and may be involved in complex gut-brain communication.
395
However the principal function of the microbiome is digestion of fibre and other carbohydrates that escape 396 breakdown in the small bowel and it is the availability of fibre in the diet that dominates the metabolism of the 397 gut microbiome and leads to protection from conditions such as colorectal cancer. 44, 45 This coming together of 398 the epidemiological and experimental work on fibre allows conclusions to be drawn that increased fibre intakes 399 should result in improvements in population health.
401
While we have not considered the evidence regarding total carbohydrate intake, epidemiological evidence and 402 relatively long term clinical trials 46 suggest that a wide range of intakes is acceptable, a finding which is 403 endorsed by authoritative dietary guidelines. 47 Our study contributes to the growing body of evidence that 404 carbohydrate quality rather than quantity determines major health outcomes. Translating these findings 405 regarding dietary fibre and whole grains into dietary advice for individuals and populations should be 406 accompanied by a caveat. Dietary fibre as defined by Codex Alimentarius is naturally occurring in foods, but 407 may be extracted from foods or synthesised and added into manufactured foods. The large body of literature 408 which contributed to this and other systematic reviews and meta analyses relate principally to fibre rich foods 409 since most of the studies were undertaken before synthetic and extracted fibre were widely used. The concept of 410 wholegrain foods has also changed appreciably. Wholegrain foods are required to have a nutrient composition 411 similar to that of the original grain, without regard to the degree of processing. Many breakfast cereals and other 412 manufactured "whole grain" products are more highly processed than in the past. There is limited, but quite 413 striking evidence that increased processing of whole grains can result in a deterioration of a several biomarkers 414 of cardiometabolic disease. 48 As these are relatively recent developments there is no epidemiological evidence 415 of the consequences of these changes in the food supply on clinical outcomes and mortality. Until such evidence 416 is available it seems appropriate that dietary advice should emphasise the benefits of naturally occurring dietary 417 fibre in whole grains, vegetables and fruits that have been minimally processed.
419
There is a considerable body of evidence relating to the adverse consequences of high intakes of sugar 420 sweetened beverages and strong recommendations to reduce the intake of free sugars. 3 Our findings based on a 421 series of systematic reviews and meta analyses provide strong evidence for the importance of including advice 422 regarding the nature and source of other carbohydrates in dietary guidelines aimed at reducing the risk of NCDs.
423
Diets high in total dietary fibre especially from whole grains and, on the basis of another recent systematic 424 review, 36 vegetables and fruits, are associated with a significant reduction in a range of NCDs when compared 425 with lower dietary fibre and refined rather than whole grain intakes. The types of studies we have considered did 426 not identify risks associated with dietary fibre. However high intakes may be associated with deleterious effects 427 in populations with borderline iron/mineral status, amongst whom very high whole grain intakes may further 428 compromise iron status. 49 High intakes of dietary fibre and whole grains are more clearly associated with good 429 health outcomes than measures of glycaemic index or glycaemic load. Whilst glycaemic index provides a 430 measure of the glycaemic potential of the carbohydrate content of foods, some low glycaemic index foods may 431 have other attributes, which are not health promoting. Foods containing added fructose or sucrose and 432 composite foods containing both saturated fat and carbohydrate (e.g. confectionary products) may have a low 433 glycaemic index. 50 Our complementary findings from randomised controlled trials and prospective studies 434 together with the dose response effects, supported by much experimental work, are evidence that diets 435 characterised by a low content of dietary fibre contribute to the cause of a number of NCDs and that benefit will 436 accrue from implementation of quantitative recommendations regarding dietary fibre intake. Intakes in the range 437 of 25 to 29g daily are optimal whilst the dose response data show that amounts greater than 30g per day confer 438 additional benefits.
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*** Only one eligible trial of children was identified in our systematic searches. Although the exposure was for diets of higher and lower GI, data from this trial has not been 592 included with that of adults shown above.
594 595
Detailed justification for the GRADE quality of evidence is given in Appendix D for observational studies and Supplement 2 for trials. Assuming linearity a reduced risk ratio of 0·93 (0·89 to 0·98) was observed for every 15 grams more whole grains consumed per day.
597
Fig 3c
Wholegrain intake and incidence of type 2 diabetes.
13,147 cases over 3·5 million person years.
Assuming linearity a reduced risk ratio of 0·88 (0·81 to 0·95) was observed for every 15 grams more whole grains consumed per day. Assuming linearity a risk ratio of 1·09 (0·94 to 1·27)
was observed for every 10 glycaemic index unit increase per day. 
Figure 5b
Higher compared with lower wholegrain intakes.
Figure 5c
Comparison of diets characterised by lower compared with higher glycaemic index foods.
